Proposals to include biologics in price controls could threaten NHS savings, says biosimilars head

Government proposals to include all biologics within the scope of price-controlled health service medicines could impact patient benefit and threaten NHS England’s savings target, the director general of the British Generic Manufacturers Association and the British Biosimilars Association has …